Clifford J L, Petkovich M, Chambon P, Lotan R
Department of Tumor Biology, University of Texas M. D. Anderson Cancer Center, Houston 77030.
Mol Endocrinol. 1990 Oct;4(10):1546-55. doi: 10.1210/mend-4-10-1546.
Retinoids inhibit the growth and enhance the differentiation of murine S91-C2 melanoma cells. Specific alterations in gene expression are a plausible mechanism for these effects. Since nuclear retinoic acid receptors (RAR) are likely mediators of retinoid-induced changes in gene expression, we used Northern blotting to analyze the expression of RAR alpha, RAR beta, and RAR gamma in S91-C2 cells. mRNA for both RAR alpha and RAR gamma was detected in these cells, but no RAR beta mRNA could be found. Treatment with 10(-7) and 10(-6) M beta-all-trans-retinoic acid (RA) for 24 h caused a 1.5- to 2-fold increase in RAR alpha and RAR gamma mRNA, whereas lower concentrations of RA were ineffective. RAR beta mRNA, which was undetectable in untreated cells, was detected after 24 h of treatment with a RA concentration as low as 10(-9) M, and its level increased with up to 10(-6) M RA. At the latter dose, RAR beta mRNA induction occurred by 4 h and increased progressively, reaching a plateau after 24 h of treatment. RAR beta mRNA induction at 4 h was not inhibited by cycloheximide at a concentration that suppressed protein synthesis by more than 90%. Several retinoids and related synthetic compounds, including 13-cis RA, TTNPB, Ch55, Am80, and the trifluoromethyl nonyloxyphenyl analog of RA, also induced RAR beta mRNA, whereas a 24-h treatment with 10(-6) M retinol, TTNP (a decarboxylated analog of TTNPB), or the phenyl analog of RA failed to induce RAR beta mRNA. With the exception of retinol and the trifluoromethyl nonyloxyphenyl analog of RA, the ability of the retinoids to induce RAR beta mRNA and their growth inhibitory effect were correlated. However, S91-C154, a RA-resistant mutant subclone derived from S91-C2 cells, showed mRNA levels of RAR alpha and RAR gamma and induction of RAR beta by RA similar to those detected in the sensitive S91-C2 cells. Like the S91 melanoma cells, two other mouse melanoma cell lines, K-1735P and B16-F1, constitutively expressed RAR alpha and RAR gamma mRNAs. The level of RAR beta mRNA was increased by RA only in B16-F1 cells, although the growth of both was inhibited by RA. These results demonstrate that RA can, directly and rapidly, induce the expression of mRNA for a high affinity nuclear receptor in some murine melanoma cells and that this induction is not sufficient to inhibit growth.
维甲酸可抑制小鼠S91 - C2黑色素瘤细胞的生长并促进其分化。基因表达的特定改变可能是这些作用的一种合理机制。由于核视黄酸受体(RAR)可能是维甲酸诱导基因表达变化的介质,我们用Northern印迹法分析了S91 - C2细胞中RARα、RARβ和RARγ的表达。在这些细胞中检测到了RARα和RARγ的mRNA,但未发现RARβ的mRNA。用10⁻⁷和10⁻⁶ M的β - 全反式维甲酸(RA)处理24小时,导致RARα和RARγ的mRNA增加了1.5至2倍,而较低浓度的RA则无效。在未处理的细胞中无法检测到的RARβ的mRNA,在用低至10⁻⁹ M的RA处理24小时后被检测到,其水平随着RA浓度增加到10⁻⁶ M而升高。在后者剂量下,RARβ的mRNA在4小时开始诱导并逐渐增加,在处理24小时后达到平台期。4小时时RARβ的mRNA诱导不受环己酰亚胺的抑制,环己酰亚胺在该浓度下可抑制蛋白质合成超过90%。几种维甲酸和相关的合成化合物,包括13 - 顺式RA、TTNPB、Ch55、Am80以及RA的三氟甲基壬氧基苯基类似物,也能诱导RARβ的mRNA,而用10⁻⁶ M视黄醇、TTNP(TTNPB的脱羧类似物)或RA的苯基类似物处理24小时未能诱导RARβ的mRNA。除了视黄醇和RA的三氟甲基壬氧基苯基类似物外,维甲酸诱导RARβ的mRNA的能力与其生长抑制作用相关。然而,S91 - C154是从S91 - C2细胞衍生的对RA耐药的突变亚克隆,其RARα和RARγ的mRNA水平以及RA对RARβ的诱导与在敏感的S91 - C2细胞中检测到的相似。与S91黑色素瘤细胞一样,另外两种小鼠黑色素瘤细胞系K - 1735P和B16 - F1组成性地表达RARα和RARγ的mRNA。只有在B16 - F1细胞中RA可增加RARβ的mRNA水平,尽管两者的生长都受到RA的抑制。这些结果表明,RA可以直接且快速地诱导一些小鼠黑色素瘤细胞中高亲和力核受体的mRNA表达,并且这种诱导不足以抑制生长。